{
      "ptx_code": "PTX198",
      "chem_name": "Acyclovir",
      "casrn": "59277-89-3",
      "dtxsid": "DTXSID1022556",
      "smiles": "NC1=NC(=O)C2=C(N1)N(COCCO)C=N2",
      "inchikey": "MKUXAQIIEYXACX-UHFFFAOYSA-N",
      "label": "PTX198 | Acyclovir",
      "drugbank_id": "DB00787",
      "use_class": "Pharmaceutical",
      "tox_class": "Nephrotoxicity; Ototoxicity; Hematotoxicity; Immunotoxicity; Neurotoxicity; Hepatotoxicity",
      "chem_name_user": "Acyclovir",
      "mw_g_mol": "225.208",
      "solubility_h2o_mol_liter": "0.0071856",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.01152e-10",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "8.38333519767323",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "",
      "pka_base": "2.17",
      "source_pka": "ACD/GALAS",
      "log_kow_liter_liter": "-1.56",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "-1.44392634551472",
      "source_dlipw": "Kow QSAR (\u00e2\u02c6\u2020mw = 1)",
      "freely_dissolved_fraction": "0.942276927352634",
      "density_kg_liter": "1.792",
      "source_density": "COMPTOX",
      "baseline_drerio": "1621810.09735893",
      "baseline_dmagna": "218776.162394955",
      "baseline_celegans": "457088.189614875",
      "baseline_xlaevis": "31067.0488278995",
      "baseline_dmelanogaster": "2022087.75840144",
      "baseline_cells": "0.275927375968422",
      "baseline_cells_generic_micromole_liter_free_ec10": "0.26",
      "moa_drugbank": "Acyclovir is becomes acyclovir monophosphate due to the action of viral thymidine kinase.[A180757] Acyclovir monophosphate is converted to the diphosphate form by guanylate kinase.[A903] Acyclovir diphosphate is converted to acyclovir triphosphate by nucleoside diphosphate kinase, pyruvate kinase, creatine kinase, phosphoglycerate kinase, succinyl-CoA synthetase, phosphoenolpyruvate carboxykinase and adenylosuccinate synthetase.[A903,A180781] Acyclovir triphosphate has higher affinity for viral DNA polymerase than cellular DNA polymerase and incorporates into the DNA where the missing 2' and 3' carbons causes DNA chain termination.[A180757] In other cases acyclovir triphosphate competes so strongly for viral DNA polymerase that other bases cannot associate with the enzyme, inactivating it.[A180757]",
      "protein_binding": "Acyclovir is 9-33% protein bound in plasma.[A180775,L7315]",
      "moa_t3db": "",
      "aop": [],
      "targets": []
}